1-3 of 3
Claus Holst-Hansen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Direct Evidence of the Importance of Stromal Urokinase Plasminogen Activator (uPA) in the Growth of an Experimental Human Breast Cancer Using a Combined uPA Gene-Disrupted and Immunodeficient Xenograft Model

Thomas Leth Frandsen, Claus Holst-Hansen, Boye Schnack Nielsen, Ib Jarle Christensen, Jens R. Nyengaard, Peter Carmeliet, Nils Brünner
Journal: Cancer Research
Cancer Res (2001) 61 (2): 532–537.
Published: 01 January 2001
View article titled, Direct Evidence of the Importance of Stromal Urokinase Plasminogen Activator (uPA) in the Growth of an Experimental Human Breast Cancer Using a Combined <em>uPA</em> Gene-Disrupted and Immunodeficient Xenograft Model
Open the PDF for Direct Evidence of the Importance of Stromal Urokinase Plasminogen Activator (uPA) in the Growth of an Experimental Human Breast Cancer Using a Combined <em>uPA</em> Gene-Disrupted and Immunodeficient Xenograft Model in another window
Journal Articles

MCF7/LCC9: An Antiestrogen-resistant MCF-7 Variant in Which Acquired Resistance to the Steroidal Antiestrogen ICI 182,780 Confers an Early Cross-Resistance to the Nonsteroidal Antiestrogen Tamoxifen

Nils Brünner, Birgitte Boysen, Stana Jirus, Todd C. Skaar, Claus Holst-Hansen, Jeremy Lippman, Thomas Frandsen, Mogens Spang-Thomsen, Suzanne A. W. Fuqua, Robert Clarke
Journal: Cancer Research
Cancer Res (1997) 57 (16): 3486–3493.
Published: 01 August 1997
View article titled, MCF7/LCC9: An Antiestrogen-resistant MCF-7 Variant in Which Acquired Resistance to the Steroidal Antiestrogen ICI 182,780 Confers an Early Cross-Resistance to the Nonsteroidal Antiestrogen Tamoxifen
Open the PDF for MCF7/LCC9: An Antiestrogen-resistant MCF-7 Variant in Which Acquired Resistance to the Steroidal Antiestrogen ICI 182,780 Confers an Early Cross-Resistance to the Nonsteroidal Antiestrogen Tamoxifen in another window
Journal Articles

MCF7/LCC2: A 4-Hydroxytamoxifen Resistant Human Breast Cancer Variant That Retains Sensitivity to the Steroidal Antiestrogen ICI 182,780

Nils Brünner, Thomas L. Frandsen, Claus Holst-Hansen, Mian Bei, Erik W. Thompson, Alan E. Wakeling, Marc E. Lippman, Robert Clarke
Journal: Cancer Research
Cancer Res (1993) 53 (14): 3229–3232.
Published: 01 July 1993
View article titled, MCF7/LCC2: A 4-Hydroxytamoxifen Resistant Human Breast Cancer Variant That Retains Sensitivity to the Steroidal Antiestrogen ICI 182,780
Open the PDF for MCF7/LCC2: A 4-Hydroxytamoxifen Resistant Human Breast Cancer Variant That Retains Sensitivity to the Steroidal Antiestrogen ICI 182,780 in another window